#4 - The Fast and the Continuous: Dolutegravir-Based Antiretroviral Therapy (...) - Jason Bacha

#4 - The Fast and the Continuous: Dolutegravir-Based Antiretroviral Therapy (...) - Jason Bacha

#14 - Optimizing Diagnostic Technologies for Pediatric HIV– Function or (...) - Clare FlanaganПодробнее

#14 - Optimizing Diagnostic Technologies for Pediatric HIV– Function or (...) - Clare Flanagan

ODYSSEY trial video 3: Does dolutegravir have side effects?Подробнее

ODYSSEY trial video 3: Does dolutegravir have side effects?

Dolutegravir + Rilpivirine Combination Therapy for HIVПодробнее

Dolutegravir + Rilpivirine Combination Therapy for HIV

Impressive Treatment Success and Safety of Dolutegravir Seen Among Adolescents... - Jason BachaПодробнее

Impressive Treatment Success and Safety of Dolutegravir Seen Among Adolescents... - Jason Bacha

Switching Antiretroviral Therapy -- Jacqueline Sherbuk, MDПодробнее

Switching Antiretroviral Therapy -- Jacqueline Sherbuk, MD

#21 - Optimizing ART for CALHIV by Shifting PI-based ART to Dolutegravir (...) - Jason BachaПодробнее

#21 - Optimizing ART for CALHIV by Shifting PI-based ART to Dolutegravir (...) - Jason Bacha

#7 - Patterns Among Infants With HIV in the Era of Universal Antiretroviral (...) - Kim AndersonПодробнее

#7 - Patterns Among Infants With HIV in the Era of Universal Antiretroviral (...) - Kim Anderson

HIV-1 drug resistance on dolutegravir-based antiretroviral therapy - Pr. Mathias EGGERПодробнее

HIV-1 drug resistance on dolutegravir-based antiretroviral therapy - Pr. Mathias EGGER

Implication of the resent Dolutegravir data | Rebecca Zash, MDПодробнее

Implication of the resent Dolutegravir data | Rebecca Zash, MD

Pharmacology - HIV antiretroviral drugs (classes, mechanism of action and side effects)Подробнее

Pharmacology - HIV antiretroviral drugs (classes, mechanism of action and side effects)

Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Original)Подробнее

Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Original)

Second-Line Dolutegravir for HIV Favorable to Other Boosted PIs - Medpage TodayПодробнее

Second-Line Dolutegravir for HIV Favorable to Other Boosted PIs - Medpage Today

Antiretroviral Therapy and PregnancyПодробнее

Antiretroviral Therapy and Pregnancy

#18 - Efficacy and Safety of Dolutegravir/Lamivudine (DTG/3TC) in (...) - Thanyawee PuthanakitПодробнее

#18 - Efficacy and Safety of Dolutegravir/Lamivudine (DTG/3TC) in (...) - Thanyawee Puthanakit

Advancements in HIV Treatment: Understanding Your OptionsПодробнее

Advancements in HIV Treatment: Understanding Your Options

Antiretroviral Therapy Cases From the Clinic(ians)Подробнее

Antiretroviral Therapy Cases From the Clinic(ians)

Efficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy VavroПодробнее

Efficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy Vavro